Optimising preoperative risk stratification tools for prostate cancer using mpMRI

Abstract

PurposeTo improve preoperative risk stratification for prostate cancer (PCa) by incorporating multiparametric MRI (mpMRI) features into risk stratification tools for PCa, CAPRA and D’Amico.Methods807 consecutive patients operated on by robot-assisted radical prostatectomy at our institution during the period 2010–2015 were followed to identify biochemical recurrence (BCR). 591 patients were eligible for final analysis. We employed stepwise backward likelihood methodology and penalised Cox cross-validation to identify the most significant predictors of BCR including mpMRI features. mpMRI features were then integrated into image-adjusted (IA) risk prediction models and the two risk prediction tools were then evaluated both with and without image adjustment using receiver operating characteristics, survival and decision curve analyses.Results37 patients suffered BCR. Apparent diffusion coefficient (ADC) and radiological extraprostatic extension (rEPE) from mpMRI were both significant predictors of BCR. Both IA prediction models reallocated more than 20% of intermediate-risk patients to the low-risk group, reducing their estimated cumulative BCR risk from approximately 5% to 1.1%. Both IA models showed improved prognostic performance with a better separation of the survival curves.ConclusionIntegrating ADC and rEPE from mpMRI of the prostate into risk stratification tools improves preoperative risk estimation for BCR.Key points• MRI-derived features, ADC and EPE, improve risk stratification of biochemical recurrence. • Using mpMRI to stratify prostate cancer patients improves the differentiation between risk groups. • Using preoperative mpMRI will help urologists in selecting the most appropriate treatment. Electronic supplementary materialThe online version of this article (10.1007/s00330-017-5031-5) contains supplementary material, which is available to authorized users.

Development and validation of a prognostic index for efficacy evaluation and prognosis of first-line chemotherapy in stage III–IV lung squamous cell carcinoma

“…Nomogram of the models was also established to evaluate their prognosis performance [ 30 ]. Decision curve analysis was performed for comparing the net benefits at different threshold probabilities given by the models [ 31 ]. The net reclassification improvement (NRI) and the integrated discrimination improvement (IDI) were also quantified for evaluating the prognostic benefit improvement of the PIM.…”

Risk model based on MRI fusion biopsy characteristics predicts biochemical recurrence after radical prostatectomy

“…In addition, some features of MRI, such as suspicious ECE, SVI, and regional lymph node metastasis, provide an important preoperative reference for RP surgery and lymph node dissection 21 . Some MRI indicators have been confirmed to be related to BCR after RP, such as the Likert score 22 and ADC value 23 . And some studies have also added clinical data to predict the risk of BCR after RP, 24 but few studies have applied mpMRI features combined with pathological data of fusion biopsy to the forecast of BCR and prognosis after RP.…”

Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study

“…It is reported that mpMRI can significantly reduce the number of unnecessary repeat prostate biopsies (45). Some researchers have tried to use mpMRI to determine risk stratification for PCa patients (46). The results showed that the fusion of mpMRI data and clinicopathological data can significantly improve the predictive model's ability to predict the recurrence of PCa disease, compared to traditional predictive models that only have clinical data.…”